We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Study Probes Role of Sestrin 3 in Glucose Metabolism and Diabetes Development

By LabMedica International staff writers
Posted on 18 Nov 2014
A recent paper discussed the role of sestrin proteins in resisting oxidative stress and regulating metabolic processes such as glucose production and insulin sensitivity, which are disrupted in type II diabetes and metabolic syndrome.

Investigators at Indiana University School of Medicine (Indianapolis, USA) focused their attention on the protein Sestrin 3 (Sesn3). More...
The gene for this protein in humans is located on chromosome 11q21. The sestrin family of proteins, of which Sesn3 is a member, comprises cysteine sulfinyl reductases, and they modulate peroxide signaling and antioxidant defense. These proteins selectively reduce or repair hyperoxidized forms of typical 2-cysteine peroxiredoxins (enzymes that metabolize peroxides) in eukaryotes.

Sestrin expression was found to be regulated by the tumor suppressor protein p53. Sesn3 was identified as a forkhead box O (FoxO) protein with antioxidant activity. Recently it was reported that Sesn3 may play an important role in Akt induced increase in reactive oxygen species (ROS), and it might be a promising target in selectively killing cancer cells containing high levels of Akt activity.

Akt, also known as protein kinase B (PKB), is a serine/threonine-specific protein kinase that plays a key role in multiple cellular processes such as glucose metabolism, apoptosis, cell proliferation, transcription, and cell migration. Akt is hyperactivated in cancer. This hyperactivity leads to an increase in intracellular ROS mainly by inhibiting the expression of ROS scavengers downstream of FoxO, such as Sesn3.

In the current study, the investigators generated Sesn3 liver-specific transgenic and knockout mice. These animals were fed a diet with 18% of its calories from fat or a high-fat diet with 60% of calories from fat.

Results published in the November 5, 2014, online edition of the journal Diabetes revealed that mice lacking Sesn3 had elevated fasting blood glucose levels, indicative of impaired liver insulin sensitivity or poorly regulated glucose metabolism. Insulin and glucose tolerance tests were significantly improved in Sesn3-positive control mice.

Biochemical analysis revealed that Sesn3 interacted with and activated mTORC2 (mechanistic target of rapamycin complex 2) and subsequently stimulated Akt phosphorylation at serine 473. These findings suggested that Sesn3 could activate Akt via mTORC2 to regulate liver insulin sensitivity and glucose metabolism.

Senior author Dr. X. Charlie Dong, associate professor of biochemistry and molecular biology at the Indiana University School of Medicine, said, "We wanted to show that Sestrin 3 had critical liver-specific functions. This is a very fascinating protein. It is not very big, but it functions in a very dynamic manner controlling glucose production and insulin sensitivity. It is an important regulator for glucose homeostasis."

Related Links:

Indiana University School of Medicine



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.